NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email Global technology companies have ramped up debt issuance this year to record levels, as an intensifying race to build artificial intelligence capacity forces even cash-rich firms to borrow heavily to fund that investment.Read More